pharmacie et médicaments – Accès aux nouveaux traitements contre le myélome multiple

This written question asks about the accessibility of new treatments for multiple myeloma, a type of blood cancer. It highlights concerns regarding patient access to innovative therapies. The question seeks to understand the current situation and potential barriers to accessing these advanced treatments for patients in France.